Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

[1]  G. Bakris.  Similarities and Differences Between the ACC/AHA and ESH/ESC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. , 2019, Circulation research.

[2]  Y. Fujii,et al.  Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .

[3]  A. Baehr.  Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomized, placebo-controlled, phase 3 superiority trial , 2018, The Journal of Emergency Medicine.

[4]  I. Roberts,et al.  Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. , 2018, Wellcome open research.

[5]  T. Steiner,et al.  Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial , 2018, BMC Research Notes.

[6]  Jay J H Park,et al.  Critical concepts in adaptive clinical trials , 2018, Clinical epidemiology.

[7]  Ashutosh Kumar Singh,et al.  The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial , 2018, Trials.

[8]  S. Gosselin,et al.  Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. , 2018, CJEM.

[9]  P. Muntner,et al.  Response to Letter to editor "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults". , 2018, Journal of the American Society of Hypertension : JASH.

[10]  D. Werring,et al.  Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial , 2018, BMJ Open.

[11]  P. Edwards,et al.  Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients , 2019 .

[12]  T. Steiner,et al.  Haemostatic therapies for acute spontaneous intracerebral haemorrhage. , 2018, The Cochrane database of systematic reviews.

[13]  S. Pocock,et al.  Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial , 2017, Trials.

[14]  C. Anderson,et al.  Intensive Blood Pressure Lowering in Intracerebral Hemorrhage. , 2017, Stroke.

[15]  I. Chalmers,et al.  Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial , 2017, The Lancet.

[16]  P. Sandercock,et al.  Increasing value and reducing waste in stroke research , 2017, The Lancet Neurology.

[17]  P. Bath,et al.  Management of acute intracerebral haemorrhage - an update. , 2017, Clinical medicine.

[18]  A. Meretoja,et al.  Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials , 2017, European stroke journal.

[19]  S. Goobie.  Tranexamic acid: still far to go. , 2017, British journal of anaesthesia.

[20]  I. Roberts,et al.  The effectiveness and safety of anti-fibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis , 2017, Wellcome Open Research.

[21]  S. Connolly,et al.  Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. , 2016, The New England journal of medicine.

[22]  Rustam Al-Shahi Salman,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[23]  T. Morita,et al.  Intensive blood pressure lowering , 2016, The Lancet.

[24]  C. Anderson,et al.  Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results , 2016, Stroke.

[25]  W. Hacke,et al.  Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial , 2016, The Lancet Neurology.

[26]  S. Pocock,et al.  Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial , 2016, International journal of stroke : official journal of the International Stroke Society.

[27]  Na Li,et al.  Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time , 2016, Stroke.

[28]  J. Abdullah,et al.  Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages. , 2015, The Malaysian journal of medical sciences : MJMS.

[29]  Bcps,et al.  Idarucizumab for dabigatran reversal , 2015 .

[30]  E. T. Investigators,et al.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial , 2015, The Lancet.

[31]  S. Zehtabchi,et al.  Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. , 2014, The American journal of emergency medicine.

[32]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[33]  P. Bath,et al.  Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[34]  S. Greenberg,et al.  Predicting hematoma expansion after primary intracerebral hemorrhage. , 2014, JAMA neurology.

[35]  G. Murray,et al.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial , 2013, The Lancet.

[36]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[37]  S. Greenberg,et al.  Hematoma Expansion following Acute Intracerebral Hemorrhage , 2013, Cerebrovascular Diseases.

[38]  公浩 古森.  末梢動脈閉塞症（Peripheral arterial disease：PAD）に対する最新の治療戦略 , 2013 .

[39]  S. Greenberg,et al.  CTA Spot Sign Predicts Hematoma Expansion in Patients with Delayed Presentation After Intracerebral Hemorrhage , 2012, Neurocritical Care.

[40]  Pablo Perel,et al.  CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial , 2012, Trials.

[41]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[42]  J. Saver,et al.  Statistical Analysis of the Primary Outcome in Acute Stroke Trials , 2012, Stroke.

[43]  G. Guyatt,et al.  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial , 2011, The Lancet.

[44]  Eric E. Smith,et al.  Defining hematoma expansion in intracerebral hemorrhage , 2011, Neurology.

[45]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[46]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[47]  Ale Algra,et al.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis , 2010, The Lancet Neurology.

[48]  T. Steiner,et al.  Options to Restrict Hematoma Expansion After Spontaneous Intracerebral Hemorrhage , 2010, Stroke.

[49]  C. Anderson,et al.  Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) , 2010, Stroke.

[50]  Nimodipine BI Orgo,et al.  Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors ? , 2009 .

[51]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[52]  A. Jaffer.  Venous thromboembolism (VTE). , 2008, Cleveland Clinic journal of medicine.

[53]  Y. Fujii,et al.  Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. , 2007, Journal of neurosurgery.

[54]  Michael D Hill,et al.  Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis , 2007, Stroke.

[55]  S. Mayer,et al.  Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage , 2007, Stroke.

[56]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[57]  H. Fodstad.  Rapid Administration of Antifibrinolytics and Strict Blood Pressure Control for Intracerebral Hemorrhage. , 2006, Neurosurgery.

[58]  S M Davis,et al.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[59]  A David Mendelow,et al.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial , 2005, The Lancet.

[60]  S. Mayer,et al.  Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage , 2005, Stroke.

[61]  F. Calenbergh,et al.  Controversies in the management of spontaneous cerebellar haemorrhage a consecutive series of 49 cases and review of the literature , 2005, Acta Neurochirurgica.

[62]  A. Algra,et al.  Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. , 2013, The Cochrane database of systematic reviews.

[63]  Robert Clarke,et al.  Utility of TICS‐M for the assessment of cognitive function in older adults , 2003, International journal of geriatric psychiatry.

[64]  A. Tyagi,et al.  Management of Spontaneous Cerebellar Hematomas: A Prospective Treatment Protocol , 2001, Neurosurgery.

[65]  R. E. Adams,et al.  Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus , 1998, Neurology.

[66]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.

[67]  Takenoriyamaguchi,et al.  Enlargement of Spontaneous Intracerebral Hemorrhage , 1996 .

[68]  Haruko Yamamoto,et al.  Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. , 1996, Stroke.

[69]  D. V. Van Riper,et al.  The Dose‐Response Relationship of Tranexamic Acid , 1995, Anesthesiology.

[70]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[71]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[72]  W. Zung.  A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.